Crombez Eric 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Apr 20, 2026
Research Summary
AI-generated summary of this filing
Ultragenyx (RARE) EVP/CMO Eric Crombez Receives RSU Award
What Happened
Eric Crombez, Executive Vice President and Chief Medical Officer of Ultragenyx Pharmaceutical (RARE), received equity awards on April 16, 2026. The filing reports two awards totaling 94,626 shares: 34,674 shares acquired as an award and 59,952 shares reported as a derivative award (both at $0.00 acquisition price). These are restricted stock unit (RSU) grants (compensation awards), not open-market purchases or sales.
Key Details
- Transaction date: 2026-04-16; Form 4 filed 2026-04-20 (filed timely).
- Awards: 34,674 RSUs (A) and 59,952 RSUs (derivative A), total 94,626 RSUs; acquisition price reported $0.00.
- Vesting: RSUs vest 1/4 on each anniversary of the grant and fully vest on the fourth anniversary (see footnote F1).
- Shares owned after transaction: not specified in this Form 4; filing notes inclusion of previously reported RSUs (footnote F2).
- Footnotes: F1 describes the 4-year annual RSU vesting; F2 notes inclusion of previously reported RSU shares; F3 describes a standard option vesting schedule (appears to be boilerplate and not the subject of the current RSU awards).
- Filing timeliness: Report appears timely (filed within required SEC window).
Context
These awards are standard equity compensation used to retain executives; they are not purchases or sales and do not represent an immediate cash investment or divestiture. The derivative designation indicates the awards are stock-settled units that will convert into common shares as they vest.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-04-16+34,674→ 110,975 total - Award
Stock Option (Right to Buy)
[F3]2026-04-16+59,952→ 59,952 totalExercise: $24.52Exp: 2036-04-16→ Common Stock (59,952 underlying)
Footnotes (3)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.